why choose us

Clinical Trials Search

Showing 20,030 of 132,963 result(s)
Physical Activity for PLWH and Unhealthy Drinking

Status: Completed

Condition: HIV

Interventions: A study interventionist will conduct phone;video sessions and provide information regarding the acute and long-term psychological and physical be

Date: 2022-08-16

A Mechanistic Test of Treatment Strategies to Foster Practice Quitting

Status: Completed

Condition: Tobacco Use

Interventions: Participants randomized to this condition will receive a 4-week nicotine replacement therapy (NRT) starter kit containing both nicotine lozenges and p

Date: 2022-08-16

Symptom Management in Patients on Dialysis

Status: Completed

Condition: End-stage Kidney Disease

Interventions:

SUPPORT-Dialysis is a symptom assessment response toolkit, consisting of a screening and response component.
Participants will be screened for

Date: 2022-08-16

Intubation Conditions Achieved With Rapid Co-administration of Rocuronium and Propofol Versus Classical Induction

Status: COMPLETED

Condition: Anesthesia

Interventions: Patients from both study groups will receive premedication in the usual fashion, typically 0-2 mg of IV midazolam at the discretion of the care team.<

Date: 2022-08-16

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced;Metastatic Castration-Resistant Prostate Cancer

Status: COMPLETED

Condition: Metastatic Castration-resistant Prostate Cancer

Interventions: SV-102 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion, by the use of a combination of

Date: 2022-08-16

Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.

Status: COMPLETED

Condition: Cardiotoxicity

Interventions: We use electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of en

Date: 2022-08-15

The Effects of Sedatives on Tobacco Use Disorder Version 2

Status: COMPLETED

Condition: Tobacco Smoking

Interventions: A single dose of IV ketamine will be administered.

Date: 2022-08-15

Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Status: COMPLETED

Condition: NAFLD

Interventions: The intervention group will receive intermittent orally administered dasatinib (100 mg;day) plus quercetin (1000 mg;day) on three consecutiv

Date: 2022-08-15

Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

Status: COMPLETED

Condition: Lung Diseases, Interstitial

Interventions: DRUG: Nintedanib - Nintedanib

Date: 2022-08-15

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Status: COMPLETED

Condition: Essential Hypertension

Interventions: DRUG: AGSAVI - Uptitation
DRUG: AGLS - Uptitration

Date: 2022-08-15